Crohn’s disease is a chronic inflammatory bowel disease that primarily affects the gastrointestinal tract, causing symptoms such as abdominal pain, diarrhea, and weight loss. Medicinal cannabis has emerged as a potential therapeutic option for managing Crohn’s disease symptoms and improving patients’ quality of life. 

Recent medical journal articles have shed light on the beneficial effects of cannabinoids in reducing inflammation and alleviating symptoms associated with Crohn’s disease. A study published in 2020 [1] explored the role of medical cannabis in inducing clinical remission and improving the quality of life in patients with Crohn’s disease. The results demonstrated a significant reduction in symptoms and improved overall well-being. 

Another study from 2021 [2] highlighted the anti-inflammatory properties of cannabinoids, which can help modulate the immune response and reduce intestinal inflammation. These studies, along with others, suggest that medical marijuana holds promise as an adjunct therapy for Crohn’s disease. However, further research is necessary to determine the optimal dosage, long-term safety, and potential interactions with other medications.

If you or someone you know is interested in starting the medical marijuana certification process, consult with your physician first.